Status:
COMPLETED
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
Lead Sponsor:
Bayer
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to obtain long-term clinical data from patients approximately 15 years after their first clinical event, who participated in the former BENEFIT 304747 study and were treat...
Eligibility Criteria
Inclusion
- All subjects who were treated at least once in BENEFIT study 304747 are eligible for inclusion in the BENEFIT 15 study
Exclusion
- Subjects who, according to the investigator's judgment, have medical, psychiatric, or other conditions that compromise the subject's ability to understand the purpose of the study
- Suspected clinical instability or unpredictability of the clinical course during the study(e.g., due to previous surgery or acute stroke)
Key Trial Info
Start Date :
September 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 24 2018
Estimated Enrollment :
261 Patients enrolled
Trial Details
Trial ID
NCT03269175
Start Date
September 29 2017
End Date
May 24 2018
Last Update
May 16 2019
Active Locations (61)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Universität Graz
Graz, Styria, Austria, 8036
2
Landeskrankenhaus - Universitätskliniken Innsbruck
Innsbruck, Austria, 6020
3
CU Saint-Luc/UZ St-Luc
Bruxelles - Brussel, Belgium, 1200
4
UZ Gent
Ghent, Belgium, 9000